Call me crazy but I am still holding my shares. I believe this is the tip of the iceberg and that we haven't seen the real mass of MNKD yet. As you know, we cleared an important hurdle today but there are more to come. The FDA is next. Hopefully there is a respectable big pharma out there that understands the huge potential of Afrezza and partners with MNKD to make Afrezza the go to therapy for diabetics around the world.